Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Patton

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Current Opinion in Endocrinology, Diabetes, and Obesity|November 6, 2007
Obesity and infertilityRenato Pasquali, Laura Patton, Alessandra Gambineri
Seminars in Perinatology|December 18, 2021
Gastrointestinal and feeding issues for infants <25 weeks of gestationLaura Patton, Diomel de la Cruz, Josef Neu
Frontiers in Oncology|June 26, 2024
Hemophagocytic lymphohistiocytosis/cytokine release syndrome secondary to neoadjuvant pembrolizumab for triple-negative breast cancer: a case studyLaura Patton, Bethany Monteith, Paul Heffernan, et al.
The Journal of Clinical Endocrinology and Metabolism|September 6, 2007
17-hydroxyprogesterone responses to gonadotropin-releasing hormone disclose distinct phenotypes of functional ovarian hyperandrogenism and polycystic ovary syndromeRenato Pasquali, Laura Patton, Patrizia Pocognoli, et al.
Clinics and Practice|July 25, 2025
A Case Series on the Efficacy of the Pharmacological Treatment of Lipedema: The Italian Experience with ExenatideLaura Patton, Valeria Reverdito, Alessandra Bellucci, et al.
Obesity (Silver Spring, Md.)|March 31, 2006
Sex difference in the relationship between the hypothalamic-pituitary-adrenal axis and sex hormones in obesityValentina Vicennati, Luana Ceroni, Silvia Genghini, et al.
The Journal of Clinical Endocrinology and Metabolism|March 16, 2007
Insulin-like factor 3: a new circulating hormone related to luteinizing hormone-dependent ovarian hyperandrogenism in the polycystic ovary syndromeAlessandra Gambineri, Laura Patton, Rosaria De Iasio, et al.
International Journal of Molecular Sciences|February 10, 2024
Observational Study on a Large Italian Population with Lipedema: Biochemical and Hormonal Profile, Anatomical and Clinical Evaluation, Self-Reported HistoryLaura Patton, Lorenzo Ricolfi, Micaela Bortolon, et al.
Diabetes|June 16, 2012
Polycystic ovary syndrome is a risk factor for type 2 diabetes: results from a long-term prospective studyAlessandra Gambineri, Laura Patton, Paola Altieri, et al.
The Journal of Clinical Endocrinology and Metabolism|July 27, 2006
Treatment with flutamide, metformin, and their combination added to a hypocaloric diet in overweight-obese women with polycystic ovary syndrome: a randomized, 12-month, placebo-controlled studyAlessandra Gambineri, Laura Patton, Antonella Vaccina, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Current Opinion in Endocrinology, Diabetes, and Obesity|November 6, 2007
Obesity and infertilityRenato Pasquali, Laura Patton, Alessandra Gambineri
Seminars in Perinatology|December 18, 2021
Gastrointestinal and feeding issues for infants <25 weeks of gestationLaura Patton, Diomel de la Cruz, Josef Neu
Frontiers in Oncology|June 26, 2024
Hemophagocytic lymphohistiocytosis/cytokine release syndrome secondary to neoadjuvant pembrolizumab for triple-negative breast cancer: a case studyLaura Patton, Bethany Monteith, Paul Heffernan, et al.
The Journal of Clinical Endocrinology and Metabolism|September 6, 2007
17-hydroxyprogesterone responses to gonadotropin-releasing hormone disclose distinct phenotypes of functional ovarian hyperandrogenism and polycystic ovary syndromeRenato Pasquali, Laura Patton, Patrizia Pocognoli, et al.
Clinics and Practice|July 25, 2025
A Case Series on the Efficacy of the Pharmacological Treatment of Lipedema: The Italian Experience with ExenatideLaura Patton, Valeria Reverdito, Alessandra Bellucci, et al.
Obesity (Silver Spring, Md.)|March 31, 2006
Sex difference in the relationship between the hypothalamic-pituitary-adrenal axis and sex hormones in obesityValentina Vicennati, Luana Ceroni, Silvia Genghini, et al.
The Journal of Clinical Endocrinology and Metabolism|March 16, 2007
Insulin-like factor 3: a new circulating hormone related to luteinizing hormone-dependent ovarian hyperandrogenism in the polycystic ovary syndromeAlessandra Gambineri, Laura Patton, Rosaria De Iasio, et al.
International Journal of Molecular Sciences|February 10, 2024
Observational Study on a Large Italian Population with Lipedema: Biochemical and Hormonal Profile, Anatomical and Clinical Evaluation, Self-Reported HistoryLaura Patton, Lorenzo Ricolfi, Micaela Bortolon, et al.
Diabetes|June 16, 2012
Polycystic ovary syndrome is a risk factor for type 2 diabetes: results from a long-term prospective studyAlessandra Gambineri, Laura Patton, Paola Altieri, et al.
The Journal of Clinical Endocrinology and Metabolism|July 27, 2006
Treatment with flutamide, metformin, and their combination added to a hypocaloric diet in overweight-obese women with polycystic ovary syndrome: a randomized, 12-month, placebo-controlled studyAlessandra Gambineri, Laura Patton, Antonella Vaccina, et al.
Pageof 2